26 results on '"Ciccone, Lucia Pia"'
Search Results
2. Heavy Ion Therapy in Brain Tumors
3. A dosiomics approach to treatment outcome modeling in carbon ion radiotherapy for skull base chordomas
4. Charged particle radiotherapy for thyroid cancer. A systematic review
5. Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719)
6. Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis
7. Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275)
8. Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833)
9. Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery
10. Impact of COVID-19 on workload burden of a complex radiotherapy facility
11. Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings
12. Thermal Ablation versus SBRT in liver tumours: pros and cons
13. Artificial Intelligence in radiotherapy: state of the art and future directions
14. Selection Criteria and Treatment Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Unfit for Platinum-Based First-Line Therapy: Results of the MOON-OSS Observational Trial
15. Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes
16. Use of an Alfa-lipoic, Methylsulfonylmethane, Boswellia Serrata and Bromelain Dietary Supplement (OPERA®) for Aromatase Inhibitors-related Arthralgia Management (AIA): a prospective phase II trial (NCT04161833)
17. ARTO trial-(NCT03449719): Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration-resistant prostate cancer undergoing I line treatment with abiraterone acetate.
18. PRIMERA trial (NCT04188275), early survival results from a prospective trial exploring impact of circulating tumor cell detection in castrate resistant prostate cancer patients undergoing abiraterone or enzalutamide I line treatment.
19. May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk?
20. ARTO trial (NCT03449719), a randomized phase II trial enrolling oligometastatic castration-resistant prostate cancer patients treated with first-line abiraterone acetate with or without stereotactic body radiation therapy: Preliminary results comprehensive of biochemical outcomes and circulating tumor cells analysis.
21. Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study
22. Impact of metastases directed radiation therapy on CDK4/6 inhibitors dose reduction and treatment discontinuation for metastatic HR+/HER2- breast cancer (MBC).
23. First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status
24. Preliminary results of a prospective assessment of androgen receptor splice variants in mCRPC patients undergoing androgen receptor targeted agents.
25. Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings
26. Efficacy and Safety of Chemotherapy after Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.